Scientists are rapidly focused on retatrutide, a promising treatment from Eli Lilly, as a potential step in weight reduction . Different than many existing approaches, retatrutide is a double -action agonist targeting simultaneously GLP-1 and GIP, hormones that influence hunger and blood sugar r… Read More